Mepolizumab reduces moderate to severe COPD exacerbations in patients with varying blood eosinophil counts and type 2 ...
bDepartment of Family Medicine, Azrieli Faculty of Medicine, Bar-Ilan University, Ramat Gan, Israel ...
Among children with exacerbation-prone asthma receiving placebo vs. mepolizumab, a significant link emerged between greater ...
Patients with mild asthma exposed to higher levels of O3 and NO2, but not PM2.5, were associated with an increased risk for asthma exacerbation.
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results